Giacomelli R, Ruscitti P, Shoenfeld Y. A Comprehensive Review on Adult onset Still’s Disease. J Autoimmun. 2018;93:24–36. https://doi.org/10.1016/j.jaut.2018.07.018.

Article  PubMed  Google Scholar 

Jamilloux Y, Gerfaud-Valentin M, Martinon F, Belot A, Henry T, Sève P. Pathogenesis of Adult-onset Still’s Disease: New Insights from the Juvenile Counterpart. Immunol Res. 2015;61(1-2):53–62. https://doi.org/10.1007/s12026-014-8561-9.

Article  CAS  PubMed  Google Scholar 

Feist E, Mitrovic S, Fautrel B. Mechanisms, Biomarkers and Targets for Adult-onset Still’s Disease. Nat Rev Rheumatol. 2018;14(10):603–18. https://doi.org/10.1038/s41584-018-0081-x.

Article  PubMed  PubMed Central  Google Scholar 

Efthimiou P, Kontzias A, Hur P, Rodha K, Ramakrishna GS, Nakasato P. Adult-onset Still’s Disease in Focus: Clinical Manifestations, Diagnosis, Treatment, and Unmet needs in the era of Targeted Therapies. Semin Arthritis Rheum. 2021;51(4):858–74. https://doi.org/10.1016/j.semarthrit.2021.06.004.

Article  PubMed  Google Scholar 

Gerfaud-Valentin M, Hot A, Huissoud C, Durieu I, Broussolle C, Seve P. Adult-onset Still’s Disease and Pregnancy: About Ten Cases and Review of the Literature. Rheumatol Int. 2014;34(6):867–71. https://doi.org/10.1007/s00296-013-2765-5.

Article  CAS  PubMed  Google Scholar 

Mok MY, Lo Y, Leung PY, Lau CS. Pregnancy Outcome in Patients with Adult Onset Still’s disease. J Rheumatol. 2004;31(11):2307–9.

PubMed  Google Scholar 

Wang Z, Chi H, Feng T, et al. Pregnancy Outcomes in Patients with Adult-onset Still’s Disease: A Cohort Study from China. Front Med (Lausanne). 2020;7:566738. https://doi.org/10.3389/fmed.2020.566738.

Article  PubMed  Google Scholar 

Castañeda S, Martínez-Quintanilla D, Martín-Varillas JL, García-Castañeda N, Atienza-Mateo B, González-Gay MA. Tocilizumab for the Treatment of Adult-onset Still’s Disease. Expert Opin Biol Ther. 2019;19(4):273–86. https://doi.org/10.1080/14712598.2019.1590334.

Article  CAS  PubMed  Google Scholar 

de Boysson H, Février J, Nicolle A, Auzary C, Geffray L. Tocilizumab in the Treatment of the Adult-onset Still’s Disease: Current Clinical Evidence. Clin Rheumatol. 2013;32(1):141–7. https://doi.org/10.1007/s10067-012-2105-2.

Article  PubMed  Google Scholar 

Kaneko Y, Kameda H, Ikeda K, et al. Tocilizumab in Patients with Adult-onset Still’s Disease Refractory to Glucocorticoid Treatment: a Randomised, Double-blind, Placebo-controlled Phase III trial. Ann Rheum Dis. 2018;77(12):1720–9. https://doi.org/10.1136/annrheumdis-2018-213920.

Article  CAS  PubMed  Google Scholar 

Nordström D, Knight A, Luukkainen R, et al. Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still’s disease. An open, Randomized, Multicenter Study. J Rheumatol. 2012;39(10):2008–11. https://doi.org/10.3899/jrheum.111549.

Article  CAS  PubMed  Google Scholar 

Gerfaud-Valentin M, Maucort-Boulch D, Hot A, et al. Adult-onset Still Disease. Medicine (Baltimore). 2014;93(2) https://doi.org/10.1097/MD.0000000000000021.

Fautrel B, Patterson J, Bowe C, et al. Systematic Review on the Use of Biologics in Adult-onset Still’s Disease. Semin Arthritis Rheum. 2023;58:152139. https://doi.org/10.1016/j.semarthrit.2022.152139.

Article  CAS  PubMed  Google Scholar 

Plaçais L, Mekinian A, Bornes M, et al. Adult Onset Still’s Disease Occurring During Pregnancy: Case-Report and Literature Review. Semin Arthritis Rheum. 2018;47(4):575–7. https://doi.org/10.1016/j.semarthrit.2017.07.003.

Article  PubMed  Google Scholar 

De Carolis S, Cianci F, Del Sordo G, et al. Adult onset Still’s disease and pregnancy. Autoimmun Rev. 2019;18(9):102356. https://doi.org/10.1016/j.autrev.2019.102356.

Article  PubMed  Google Scholar 

Choy EH, De Benedetti F, Takeuchi T, Hashizume M, John MR, Kishimoto T. Translating IL-6 Biology into Effective Treatments. Nat Rev Rheumatol. 2020;16(6):335–45. https://doi.org/10.1038/s41584-020-0419-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kotch C, Barrett D, Teachey DT. Tocilizumab for the Treatment of Chimeric Antigen Receptor T Cell-induced Cytokine Release Syndrome. Expert Rev Clin Immunol. 2019;15(8):813–22. https://doi.org/10.1080/1744666X.2019.1629904.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosas IO, Bräu N, Waters M, et al. Tocilizumab in Hospitalized Patients with Severe COVID-19 Pneumonia. N Engl J Med. 2021;384(16):1503–16. https://doi.org/10.1056/NEJMoa2028700.

Article  CAS  PubMed  Google Scholar 

REMAP-CAP Investigators, Gordon AC, Mouncey PR, et al. Interleukin-6 Receptor Antagonists in Critically ill Patients with COVID-19. N Engl J Med. 2021;384(16):1491–502. https://doi.org/10.1056/NEJMoa2100433.

Article  Google Scholar 

Nakajima K, Watanabe O, Mochizuki M, Nakasone A, Ishizuka N, Murashima A. Pregnancy Outcomes After Exposure to Tocilizumab: a Retrospective Analysis of 61 Patients in Japan. Mod Rheumatol. 2016;26(5):667–71. https://doi.org/10.3109/14397595.2016.1147405.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoeltzenbein M, Beck E, Rajwanshi R, et al. Tocilizumab use in Pregnancy: Analysis of a Global Safety Database including Data from Clinical Trials and Post-marketing Data. Semin Arthritis Rheum. 2016;46(2):238–45. https://doi.org/10.1016/j.semarthrit.2016.05.004.

Article  CAS  PubMed  Google Scholar 

Imaizumi C, Saito M, Abe F, et al. Adult-onset Still’s Disease During Pregnancy Treated with Tocilizumab. Intern Med. 2022;61(20):3137–40. https://doi.org/10.2169/internalmedicine.8886-21.

Article  PubMed  PubMed Central  Google Scholar 

Moriyama M, Wada Y, Minamoto T, Kondo M, Honda M, Murakawa Y. Unexpectedly Lower Proportion of Placental Transferred Tocilizumab Relative to Whole Immunoglobulin G: a Case Report. Scand J Rheumatol. 2020;49(2):165–6. https://doi.org/10.1080/03009742.2019.1639821.

Article  CAS  PubMed  Google Scholar 

Louchet M, Sibiude J, Peytavin G, Picone O, Tréluyer JM, Mandelbrot L. Placental Transfer and Safety in Pregnancy of Medications Under Investigation to Treat Coronavirus Disease 2019. Am J Obstet Gynecol MFM. 2020;2(3):100159. https://doi.org/10.1016/j.ajogmf.2020.100159.

Saito J, Yakuwa N, Kaneko K, et al. Tocilizumab During pregnancy and Lactation: Drug Levels in Maternal Serum, Cord Blood, Breast Milk and Infant Serum. Rheumatology (Oxford). 2019;58(8):1505–7. https://doi.org/10.1093/rheumatology/kez100.

Article  PubMed  Google Scholar